NovoCure Ltd (NVCR): Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

NovoCure Limited (NVCR) - corporate logo

NovoCure Limited (NVCR) owns state-of-the-art manufacturing facilities in the US and Switzerland, ensuring the assembly precision of TTFields devices. The brand's environmental responsibility is reflected in the recycling of portable generator batteries. The EV/EBITDA multiple trend on the GURU.Markets chart demonstrates capital efficiency, where 0.00 captures the current value of the indicator. Stable management is currently preparing the platform for therapy expansion while awaiting critical regulatory decisions.

NovoCure Corp - NVCR Company Value to EBITDA (period 11/23/2025 - 11/17/2026)

Metric breakdowns and analytics for NovoCure Ltd (NVCR)

- current price and projected stock value:
- stock exchange capitalization data:
Comprehensive company analysis:NovoCure Limited (NVCR)
Manufactured products of NovoCure

The current value of 0.00 allows for an assessment of the asset's investment attractiveness via the ratio of enterprise value to EBITDA. Analysis of the EV/EBITDA multiple chart for NovoCure Limited (NVCR) reveals a dependence of the market value on the debt load, which is critical given the expectations for the inclusion of Tumor Treating Fields therapy in insurance plans and the expansion of its clinical application.